JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB312518

Alexa Fluor® 568 Anti-Lin28A antibody [EPR4640]

Be the first to review this product! Submit a review

|

(0 Publication)

Rabbit Recombinant Monoclonal Lin28A antibody - conjugated to Alexa Fluor® 568.

View Alternative Names

CSDD1, LIN28, ZCCHC1, LIN28A, Protein lin-28 homolog A, Lin-28A, Zinc finger CCHC domain-containing protein 1

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-Lin28A antibody [EPR4640]

  • 578 PE

    PE Anti-Lin28A antibody [EPR4640]

  • 660 APC

    APC Anti-Lin28A antibody [EPR4640]

  • HRP

    HRP Anti-Lin28A antibody [EPR4640]

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-Lin28A antibody [EPR4640]

  • 617 Alexa Fluor® 594

    Alexa Fluor® 594 Anti-Lin28A antibody [EPR4640]

  • 565 Alexa Fluor® 555

    Alexa Fluor® 555 Anti-Lin28A antibody [EPR4640]

  • Unconjugated

    Anti-Lin28A antibody [EPR4640]

  • Carrier free

    Anti-Lin28A antibody [EPR4640] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR4640

Isotype

IgG

Conjugation

Alexa Fluor® 568

Excitation/Emission

Ex: 578nm, Em: 603nm

Carrier free

No

Applications

Antibody Labelling, Target Binding Affinity

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Product details

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

How are conjugated primary antibodies validated?
This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling.
For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 30% Glycerol (glycerin, glycerine), 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle|Store in the dark

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

RNA-binding protein that inhibits processing of pre-let-7 miRNAs and regulates translation of mRNAs that control developmental timing, pluripotency and metabolism (PubMed : 21247876). Seems to recognize a common structural G-quartet (G4) feature in its miRNA and mRNA targets (Probable). 'Translational enhancer' that drives specific mRNAs to polysomes and increases the efficiency of protein synthesis. Its association with the translational machinery and target mRNAs results in an increased number of initiation events per molecule of mRNA and, indirectly, in mRNA stabilization. Binds IGF2 mRNA, MYOD1 mRNA, ARBP/36B4 ribosomal protein mRNA and its own mRNA. Essential for skeletal muscle differentiation program through the translational up-regulation of IGF2 expression. Suppressor of microRNA (miRNA) biogenesis, including that of let-7, miR107, miR-143 and miR-200c. Specifically binds the miRNA precursors (pre-miRNAs), recognizing an 5'-GGAG-3' motif found in pre-miRNA terminal loop, and recruits TUT4 and TUT7 uridylyltransferases (PubMed : 18951094, PubMed : 19703396, PubMed : 22118463, PubMed : 22898984). This results in the terminal uridylation of target pre-miRNAs (PubMed : 18951094, PubMed : 19703396, PubMed : 22118463, PubMed : 22898984). Uridylated pre-miRNAs fail to be processed by Dicer and undergo degradation. The repression of let-7 expression is required for normal development and contributes to maintain the pluripotent state by preventing let-7-mediated differentiation of embryonic stem cells (PubMed : 18951094, PubMed : 19703396, PubMed : 22118463, PubMed : 22898984). Localized to the periendoplasmic reticulum area, binds to a large number of spliced mRNAs and inhibits the translation of mRNAs destined for the ER, reducing the synthesis of transmembrane proteins, ER or Golgi lumen proteins, and secretory proteins. Binds to and enhances the translation of mRNAs for several metabolic enzymes, such as PFKP, PDHA1 or SDHA, increasing glycolysis and oxidative phosphorylation. Which, with the let-7 repression may enhance tissue repair in adult tissue (By similarity).
See full target information LIN28A

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com